Paxlovid ndi mankhwala ofufuzira omwe amagwiritsidwa ntchito pochiza COVID-19 wofatsa mpaka pang'ono mwa akulu ndi ana [wazaka 12 ndi kupitilira apo olemera mapaundi 88 osachepera (40 kg)] ndi zotsatira zabwino zakuyezetsa ma virus mwachindunji kwa SARS-CoV-2, ndi omwe ali pachiwopsezo chachikulu chakukula kwa COVID-19, kuphatikiza kugonekedwa m'chipatala kapena imfa. Paxlovid ndi yofufuza chifukwa ikuphunziridwabe. Pali chidziwitso chochepa chokhudza chitetezo ndi mphamvu yogwiritsira ntchito Paxlovid pochiza anthu omwe ali ndi COVID-19 wofatsa mpaka pang'ono.
A FDA avomereza kugwiritsa ntchito kwadzidzidzi kwa Paxlovid pochiza COVID-19 yofatsa mpaka pang'onopang'ono mwa akulu ndi ana [azaka 12 ndi kupitilira apo omwe amalemera mapaundi 88 (40 kg)] ndikuyezetsa kuti ali ndi kachilomboka. zimayambitsa COVID-19, ndipo omwe ali pachiwopsezo chachikulu chopitira ku COVID-19, kuphatikiza kugona m'chipatala kapena kufa, pansi pa EUA.

Paxlovid si mankhwala ovomerezeka ndi FDA ku United States. Lankhulani ndi wothandizira zaumoyo wanu za zomwe mungasankhe kapena ngati muli ndi mafunso. Ndi kusankha kwanu kutenga Paxlovid.

Paxlovid ili ndi mankhwala awiri: nirmatrelvir ndi ritonavir.

Nirmatrelvir [PF-07321332] ndi SARS-CoV-2 main protease (Mpro) inhibitor (yomwe imadziwikanso kuti SARS-CoV2 3CL protease inhibitor) yomwe imagwira ntchito poletsa kufalikira kwa ma virus koyambirira kwa matendawa kuti asapitirire ku COVID- 19.

Ritonavir imayendetsedwa limodzi ndi nirmatrelvir kuti ithandizire kuchepetsa kagayidwe kake kuti ikhalebe yogwira ntchito mthupi kwa nthawi yayitali kwambiri kuti ithandizire kuthana ndi kachilomboka.